David Vodak

Bend Bioscience

BIOGRAPHY

David has over 20 years of experience in the pharmaceutical field, specializing in drug delivery technologies. Currently the Chief Scientific Officer at Bend Bioscience, he has contributed to over 40 scientific and industry publications and holds more than 20 patents related to drug delivery across various modalities. 

David's career includes a significant role at Bend Research (now part of Lonza), where he led R&D for North America and later served as Global Head of R&D for Small Molecules. His work has focused on bioavailability enhancement, particle engineering, and non-invasive delivery of biologics.